Kestra Medical Technologies Ltd. logo

Kestra Medical Technologies Ltd.

KMTS | NASDAQ
Chart Builder DCF Calculator
$24.77
+$0.34 (+1.39%)
At close: Sep 21, 2026, 4:00 PM ET
$24.77
$0 (0.00%)
Pre-market: Sep 22, 2026, 4:30 AM ET

Market Data

Market Cap
$1.45B
Enterprise Value
$1.26B
Beta
0.62
Average Volume
335.73K
Shares Outstanding (Diluted)
58.57M
Shares Change YoY
14.15%
Institutional Ownership
N/A
Exchange
NASDAQ
ISIN
BMG524411052

Price Performance

Price Change 1M
-8.2%
Price Change 3M
19.7%
Price Change 6M
20.4%
Price Change YTD
1.6%
Price Change 1Y
-3.0%
Price Change 3Y
18.0%
Price Change 5Y
18.0%
1M CAGR (ann.)
-6.2%
1Y CAGR (ann.)
-1.7%
5Y CAGR (ann.)
N/A
All-Time CAGR
8.5%

Valuation

PE Ratio
-9.28
Forward PE
N/A
PEG Ratio
-0.59
Forward PEG
0.67
PS Ratio
13.60
Forward PS
10.30
PB Ratio
6.53
P/FCF Ratio
-11.82
P/Adj. FCF Ratio
-9.61
P/OCF Ratio
-16.51
EV/Sales
11.77
EV/EBIT
-8.97
EV/EBITDA
-8.58
EV/FCF
-10.23
Earnings Yield
-10.8%
FCF Yield
-8.5%
Adj. FCF Yield
-10.4%

Financial Health

Net Cash
$194.98M
Total Debt
$3.95M
Cash & Short-Term Investments
$198.91M
Total Assets
$347.36M
Current Ratio
4.69
Quick Ratio
4.69
Debt / Equity Ratio
0.34
Debt / EBITDA
-0.03
Debt / FCF
-0.03
OCF / Debt
-22.20
Interest Coverage
-18.98
Altman Z-Score
3.75
Piotroski F-Score
5

Margins & Profitability

Gross Profit Margin
53.9%
Operating Profit Margin
-134.5%
EBITDA Margin
-134.8%
Net Profit Margin
-140.4%
FCF Margin
-115.0%
Adj. FCF Margin
-141.5%
SBC / Revenue
26.5%
SBC Impact (per share)
-23.0%

Returns

Return on Assets
-43.1%
Return on Equity
-64.2%
Return on Invested Capital
-48.0%
Return on Capital Employed
-48.0%
Return on Tangible Assets
-43.1%

Historical Growth (CAGR)

Revenue CAGR 3Y
55.5%
Revenue CAGR 5Y
N/A
Revenue CAGR 10Y
N/A
EPS CAGR 3Y
-25.2%
EPS CAGR 5Y
N/A
EPS CAGR 10Y
N/A
FCF CAGR 3Y
-29.3%
FCF CAGR 5Y
-22.6%
FCF CAGR 10Y
N/A

Analyst Forecasts

Analyst Rating
Buy
Analyst Count
4
EPS Growth Next 3Y
11.6%
Revenue Growth Next 3Y
34.4%
Earnings Date
Dec 9, 2026
EPS Estimate (next Q)
-$0.61
EPS Growth Est (next Q)
-1.6%
Revenue Est (next Q)
$32.03M
Revenue Growth Est (next Q)
41.9%

Fair Value Estimates

Graham Number
N/A
Graham Upside
N/A
Lynch Fair Value
N/A
Lynch Upside
N/A
Price Target
$30.67
Price Target Upside
23.8%

Cash Flow

Operating Cash Flow
$-87.72M
Free Cash Flow
$-122.79M
Adj. Free Cash Flow
$-151.06M
FCF Per Share
-$2.10
OCF Per Share
-$1.50
OCF/S Ratio
-82.2%

Income Statement

Revenue
$106.73M
Gross Profit
$57.51M
Operating Income
$-143.52M
EBITDA
$-146.52M
Net Income
$-149.87M
EPS (Diluted)
-$2.67
Revenue / Employee
$240.92K
Profit / Employee
$-338.31K
Employees
443

© 2026 bestshares.com. All rights reserved.